Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis: ORIGINAL ARTICLE

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 4, 2010, Pages 395-402

  Ott, H ^a   Wilke, J ^b   Baron, J M ^a   Hoger P H ^c   Folster Holst R ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Catholic Children's Hospital Wilhelmstift   (Germany)

Author keywords

Atopic dermatitis; Biomarker; SCD14; SCD23; SCD25; SCD30

Indexed keywords

CD14 ANTIGEN; CD23 ANTIGEN; CD30 ANTIGEN; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOOD ALLERGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD14; ANTIGENS, CD30; ASTHMA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EOSINOPHIL CATIONIC PROTEIN; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; INFANT; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; PHENOTYPE; RECEPTORS, IGE; RECEPTORS, IMMUNOLOGIC; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

EID: 77749327975     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03419.x     Document Type: Article

References (54)

1. Asher MI, Montefort S, Bjorksten B et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006 368 : 733 743.
2. Novak N. New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy 2009 64 : 265 275.
3. Bieber T. Atopic dermatitis. N Engl J Med 2008 358 : 1483 1494.
4. D'Elios MM, Romagnani P, Scaletti C et al. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leukoc Biol 1997 61 : 539 544.
5. Bengtsson A, Holm L, Back O et al. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol 1997 109 : 533 537.
6. Dummer W, Brocker EB, Bastian BC. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis. Br J Dermatol 1997 137 : 185 187.
7. Nafar M, Farrokhi F, Vaezi M et al. Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection. Int Urol Nephrol 2009 41 : 687 693.
8. Savolainen E, Matinlauri I, Kautiainen H et al. Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome. Clin Exp Rheumatol 2008 26 : 922 925.
9. Hoeger PH, Niggemann B, Ganschow R et al. Serum levels of sCD23 and sCD25 in children with asthma and in healthy controls. Allergy 1994 49 : 217 221.
10. Pumputiene I, Emuzyte R, Dubakiene R et al. T cell and eosinophil activation in mild and moderate atopic and nonatopic children's asthma in remission. Allergy 2006 61 : 43 48.
11. Matsumoto K, Taki F, Miura M et al. Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma. Chest 1994 105 : 681 686.
12. Conrad DH, Ford JW, Sturgill JL et al. CD23: an overlooked regulator of allergic disease. Curr Allergy Asthma Rep 2007 7 : 331 337.
13. Zdolsek HA, Jenmalm MC. Reduced levels of soluble CD14 in atopic children. Clin Exp Allergy 2004 34 : 532 539.
14. Garty BZ, Monselise Y, Nitzan M. Soluble CD14 in children with status asthmaticus. Isr Med Assoc J 2000 2 : 104 107.
15. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980 92 : 44 77.
16. Kunz B, Oranje AP, Labreze L et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997 195 : 10 19.
17. Park JH, Choi YL, Namkung JH et al. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol 2006 155 : 778 783.
18. Ott H, Stanzel S, Ocklenburg C et al. Total Serum Immunoglobulin E as a Parameter to Differentiate Between Intrinsic and Extrinsic Atopic Dermatitis in Children. Acta Derm Venereol Suppl (Stockh) 2009 89 : 257 261.
19. Wuthrich B, Kagi MK, Joller-Jemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992 284 : 339 342.
20. Frezzolini A, Paradisi M, Ruffelli M et al. Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997 52 : 106 109.
21. Frezzolini A, Paradisi M, Zaffiro A et al. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Allergy 2002 57 : 815 820.
22. Katoh N, Hirano S, Suehiro M et al. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Clin Exp Immunol 2000 121 : 187 192.
23. Di LG, Gangemi S, Merendino RA et al. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index. Mediators Inflamm 2003 12 : 123 125.
24. Ohshima Y, Katamura K, Miura M et al. Serum levels of interleukin 4 and soluble CD23 in children with allergic disorders. Eur J Pediatr 1995 154 : 723 728.
25. Piancatelli D, Bellotta L, Del BT et al. Total IL-12 levels are increased in paediatric atopic dermatitis: correlations with age and disease severity. Int J Immunopathol Pharmacol 2008 21 : 359 365.
26. Chen JY, Fu LS, Chu JJ et al. Plasma soluble CD30 level correlates negatively with age in children. J Microbiol Immunol Infect 2007 40 : 168 172.
27. Krampera M, Vinante F, Tavecchia L et al. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Clin Exp Immunol 1999 117 : 291 297.
28. Liu AH. Innate microbial sensors and their relevance to allergy. J Allergy Clin Immunol 2008 122 : 846 858.
29. Levan TD, Michel O, Dentener M et al. Association between CD14 polymorphisms and serum soluble CD14 levels: effect of atopy and endotoxin inhalation. J Allergy Clin Immunol 2008 121 : 434 440.
30. Lodrup Carlsen KC, Lovik M, Granum B et al. Soluble CD14 at 2 yr of age: gender-related effects of tobacco smoke exposure, recurrent infections and atopic diseases. Pediatr Allergy Immunol 2006 17 : 304 312.
31. Nickel R, Illi S, Lau S et al. Variability of total serum immunoglobulin E levels from birth to the age of 10 years. A prospective evaluation in a large birth cohort (German Multicenter Allergy Study). Clin Exp Allergy 2005 35 : 619 623.
32. Ingram JM, Rakes GP, Hoover GE et al. Eosinophil cationic protein in serum and nasal washes from wheezing infants and children. J Pediatr 1995 127 : 558 564.
33. Fitch PS, Brown V, Schock BC et al. Serum eosinophil cationic protein (ECP): reference values in healthy nonatopic children. Allergy 1999 54 : 1199 1203.
34. Silva AC, Levy L, Trindade JC et al. Faecal and serum levels of eosinophil cationic protein in a healthy paediatric population. Scand J Clin Lab Invest 2007 67 : 757 766.
35. Brenninkmeijer EE, Spuls PI, Legierse CM et al. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol 2008 58 : 407 414.
36. Kusel MM, Holt PG, de KN et al. Support for 2 variants of eczema. J Allergy Clin Immunol 2005 116 : 1067 1072.
37. Folster-Holst R, Pape M, Buss YL et al. Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy 2006 61 : 629 632.
38. Gerdes S, Kurrat W, Mrowietz U. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis. Br J Dermatol. 2009 160 : 736 740.
39. Aral M, Arican O, Gul M et al. The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis. Mediators Inflamm 2006 2006 : 73098.
40. Raap U, Werfel T, Goltz C et al. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy 2006 61 : 1416 1418.
41. Hon KL, Leung TF, Ma KC et al. Urinary leukotriene E4 correlates with severity of atopic dermatitis in children. Clin Exp Dermatol 2004 29 : 277 281.
42. Oflazoglu E, Simpson EL, Takiguchi R et al. CD30 expression on CD1a+ and CD8 + cells in atopic dermatitis and correlation with disease severity. Eur J Dermatol 2008 18 : 41 49.
43. Kanbe T, Soma Y, Kawa Y et al. Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity. Br J Dermatol 2001 144 : 1148 1153.
44. Taniuchi S, Chihara J, Kojima T et al. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2001 26 : 79 82.
45. Folster-Holst R, Henseler T, Wehde J et al. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis. Acta Derm Venereol 2002 82 : 245 248.
46. Caproni M, Salvatore E, Cardinali C et al. Soluble CD30 and cyclosporine in severe atopic dermatitis. Int Arch Allergy Immunol 2000 121 : 324 328.
47. Bottari V, Frezzolini A, Ruffelli M et al. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention. Allergy 1999 54 : 507 510.
48. Heshmat NM, El-Hadidi ES. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Pediatr Allergy Immunol 2006 17 : 297 303.
49. Furue M, Koga T, Yamashita N. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 1999 140 : 67 72.
50. Yamashiro M, Okubo Y, Kato Y et al. [The study of immunological markers in patients with "intrinsic" type atopic dermatitis]. Arerugi 2002 51 : 552 558.
51. Yoshizawa Y, Nomaguchi H, Izaki S et al. Serum cytokine levels in atopic dermatitis. Clin Exp Dermatol 2002 27 : 225 229.
52. Greally P, Hussain MJ, Price JF et al. Interleukin-1 alpha and soluble interleukin-2 receptor in atopic dermatitis. Arch Dis Child 1992 67 : 1413.
53. Tanaka A, Ohashi Y, Nakai Y. Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1999 108 : 193 200.
54. Turktas I, Demirsoy S, Koc E et al. Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma. Arch Dis Child 1996 75 : 314 318. (Pubitemid 26354602)